Literature DB >> 11083717

Churg-Strauss syndrome: is there an association with leukotriene modifiers?

S Stoloff, D A Stempel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083717     DOI： 10.1378/chest.118.5.1515

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Transforming growth factor beta2 induced pleurodesis is not inhibited by corticosteroids.

Authors:  Y C Lee; C J Devin; L R Teixeira; J T Rogers; P J Thompson; K B Lane; R W Light
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 2.  Benefit-risk assessment of antileukotrienes in the management of asthma.

Authors:  Luis García-Marcos; Antje Schuster; Eduardo G Pérez-Yarza
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 3.  Comparison of medical and surgical treatment of nasal polyposis.

Authors:  Glenis K Scadding
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 4.  New and emerging prophylactic agents for migraine.

Authors:  Abouch V Krymchantowski; Marcelo E Bigal; Pedro F Moreira
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.